Professor Robert Moots and Dr Steven Young (University of Birmingham School of Immunity and Infection), discuss the therapeutic role of antibodies given directly to patients and their response to these antibodies. They review a paper by Krentil et al
Professor Robert Moots and Dr Steven Young (University of Birmingham School of Immunity and Infection), discuss the therapeutic role of antibodies given directly to patients and their response to these antibodies. They review a paper by Krentil et al
Professor Robert Moots and Dr Steven Young (University of Birmingham School of Immunity and Infection), discuss the therapeutic role of antibodies given directly to patients and their response to these antibodies. They review a paper by Krentil et al
Professor Robert Moots and Professor Pascal Richette from Lariboisière Hospital in France, discuss urate lowering therapy for the treatment of gout highlighting the issues that are encountered. They review a paper by Mitha et al on the use of rilonacept
Professor Robert Moots and Professor Pascal Richette from Lariboisière Hospital in France, discuss urate lowering therapy for the treatment of gout highlighting the issues that are encountered. They review a paper by Mitha et al on the use of rilona
Professor Robert Moots and Professor Pascal Richette from Lariboisière Hospital in France, discuss urate lowering therapy for the treatment of gout highlighting the issues that are encountered. They review a paper by Mitha et al on the use of rilonacept
Professor Robert Moots and Professor Pascal Richette from Lariboisière Hospital in France, discuss urate lowering therapy for the treatment of gout highlighting the issues that are encountered. They review a paper by Mitha et al on the use of rilona
Professor Robert Moots and Professor Pascal Richette from Lariboisière Hospital in France, discuss urate lowering therapy for the treatment of gout highlighting the issues that are encountered. They review a paper by Mitha et al on the use of rilona
Professor Robert Moots and Professor Nemanja Damjanov, the Head of Institute of Rheumatology in Belgrade, discuss the role of patients in the management of RA and the implications this has for their treatment. They review a paper by Dougados et al o
Professor Robert Moots and Professor Nemanja Damjanov, the Head of Institute of Rheumatology in Belgrade, discuss the role of patients in the management of RA and the implications this has for their treatment. They review a paper by Dougados et al o
13 min
About The Rheumatology Podcast
From the publisher's feed
Rheumatology provides free podcast interviews with experts in the field on key topics.